Professor Dominique Bremond-Gignac is the Head of Ophthalmology at University Hospital Necker-Enfants Malades of Paris Cité University in Paris, France. In this interview, we chatted with her about her experiences of combination treatment; in particular, with prescribing HOYA MiYOSMART spectacle lenses and atropine for children with myopia.
The most important step in successful orthokeratology (ortho-k) fitting starts with identifying suitable candidates. From there, obtaining high-quality corneal topography maps, lens fitting, and adhering to an appropriate follow-up schedule define the process. If you’re getting started in orthokeratology, it’s a good idea to begin with a straightforward patient, such as those described below. This article will discuss who the ideal candidates are for ortho-k.
We speak to Peter Nijhuis, Division Head Myopia Management Business Division at Menicon about the Menicon Bloom comprehensive system for myopia management with contact lenses, and about three years of experience in the Netherlands with this landmark system.
The evolution of soft contact lens design from myopia control has come from presbyopia designs to a variety of options today. The newest design is concentric annular zones with noncoaxial relative plus power, called RingBoost technology. The aim is to deliver a high level of relative plus power for increased myopia control efficacy with minimal visual impact – learn more here.
We talk to Dr May Zhang and Jeff Brown, leaders at HOYA Vision Care, about the importance of outdoor time and sun protection when it comes to managing children with myopia progression and how we can incorporate this into our clinical practice.
We speak to these leading clinical researchers on the science behind the MiSight® 1 day contact lenses and how the findings of this study can be translated into clinical practice. Both Professor Debbie Jones and Professor Nicola Logan were investigators in the MiSight 1 day clinical trial, which is the longest-running soft contact lens study involving children.
We asked renowned myopia scientist and educator Professor Mark Bullimore about his paper on this topic, which clearly outlines that the benefits outweigh the risks with myopia control. Learn about why this analysis was explored, an overview of the paper and the take-home message for clinical practice, especially for childhood contact lens wear.
There’s a lot we already know about Essilor Stellest spectacle lenses for correcting and controlling myopia. This article explores recent published studies on visual fields, a crossover trial and the 3-year and 4-year clinical trial data.
We asked some key atropine questions of myopia thought leader Professor Mark Bullimore, who has published numerous landmark papers in the field, including his newest on the inconsistencies found in compounded atropine. Learn about the present and the future of atropine treatment for childhood myopia.
We had the privilege of chatting with Professor Karla Zadnik who is Principal Investigator of the CHAMP study on low-concentration atropine. Learn about how this study is a unique and important addition to our understanding of topical atropine in myopia control.
